According to the association, such an approach undermines the predictability of Greece’s reimbursement system and erodes confidence in institutional decision-making. Refrain from imposing retroactive clawback charges on medicines supplied through the “Prolamvano” program. According to the association, such an approach undermines the predictability of Greece’s reimbursement system and erodes confidence in institutional decision-making. SFEE is calling on the government to:Recognize that clawback should not apply to medicines that have never sought reimbursement. Refrain from imposing retroactive clawback charges on medicines supplied through the “Prolamvano” program.